Park M S, Yim A S, Chung S H, Lee E Y, Cha M K, Kim J H, Song K I, Han D C, Hwang S D, Moon C, Lee H B
Hyonam Kidney Laboratory, Soon Chun Hyang University, Seoul, Korea.
Blood Purif. 1998;16(3):171-8. doi: 10.1159/000014331.
We conducted a prospective randomized controlled study to confirm our earlier observation that prolonged subcutaneous implantation of peritoneal catheter reduced peritonitis rate when compared to retrospective data from patients with catheters placed by conventional access technique. A total of 60 patients were randomized into two groups: 30 patients had catheters left implanted subcutaneously for 6 weeks (I) and the other 30 patients had catheters inserted by conventional technique and had 6 weeks of break-in period (C). Subgroups of 15 patients each with new and conventional techniques used Y-connector (IY, CY) and remaining patients used standard spikes (IS, CS). Mean age was 47.7 years (range 16-71); 61.0% were male and 44.1% diabetics. Peritonitis, exit site infection, simultaneous peritonitis and exit site infection, and complication related to Staphylococcus or Pseudomonas infections were observed for up to 2 years in each patient after initiation of bag exchange or until termination of CAPD by transfer to hemodialysis or by death. Total duration of observation was 493.2 patient-months for new access technique and 409.6 patient-months for conventional technique. Patients in IY group had the lowest incidence of peritonitis (1/14.9 patient-months) and exit site infection (1/16.8 patient-months) among four subgroups. Peritonitis rate in IY was significantly lower compared to CY or CS. The total peritonitis-free period in those patients who did not experience peritonitis during the observation period was also significantly longer in IY (120 patient-months) than in CY (26 patient-months), IS (10.6 patient-months), or CS (10.4 patient-months). Simultaneous peritonitis and exit site infection was observed in none of IY group but 3 episodes in CY, 4 episodes in IS, and 3 episodes in CS. The rates of complications related to Staphylococcus aureus and Pseudomonas infections were also significantly lower in IY than in CY, IS, or CS. Technique survival did not differ between the two groups. The present results confirm our previous observation that the new access technique reduces the incidence of peritonitis probably by reducing infection via periluminal route. The Y-connector system further reduces peritonitis rate by reducing infection via intraluminal route.
我们进行了一项前瞻性随机对照研究,以证实我们早期的观察结果:与采用传统置管技术的患者的回顾性数据相比,延长腹膜导管皮下植入时间可降低腹膜炎发生率。共有60例患者被随机分为两组:30例患者的导管皮下植入6周(I组),另外30例患者采用传统技术置管并经历6周的磨合期(C组)。每组15例患者的亚组中,新方法组和传统方法组分别使用Y型接头(IY组、CY组),其余患者使用标准接头(IS组、CS组)。平均年龄为47.7岁(范围16 - 71岁);61.0%为男性,44.1%为糖尿病患者。在开始换液后,对每位患者观察长达2年,观察腹膜炎、出口处感染、同时发生的腹膜炎和出口处感染以及与金黄色葡萄球菌或铜绿假单胞菌感染相关的并发症,直至因转为血液透析或死亡而终止持续性非卧床腹膜透析(CAPD)。新置管技术的总观察时长为493.2患者 - 月,传统技术为409.6患者 - 月。IY组在四个亚组中腹膜炎发生率最低(1/14.9患者 - 月),出口处感染发生率也最低(1/16.8患者 - 月)。IY组的腹膜炎发生率显著低于CY组或CS组。在观察期内未发生腹膜炎的患者,其无腹膜炎总时长在IY组(120患者 - 月)也显著长于CY组(26患者 - 月)、IS组(10.6患者 - 月)或CS组(10.4患者 - 月)。IY组未观察到同时发生的腹膜炎和出口处感染,而CY组有3例、IS组有4例、CS组有3例。IY组与金黄色葡萄球菌和铜绿假单胞菌感染相关的并发症发生率也显著低于CY组、IS组或CS组。两组的技术生存率无差异。目前的结果证实了我们之前的观察结果,即新的置管技术可能通过减少经管周途径的感染来降低腹膜炎的发生率。Y型接头系统通过减少经管腔内途径的感染进一步降低了腹膜炎发生率。